© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
A path to the future in scleroderma
1Department of Rheumatology, Center for Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Biomedicine, Division of Rheumatology, AOUC, Denothe Center, University of Florence, Florence, Italy, 3Department for Internal Medicine and Rheumatology, Justus-Liebig University Giessen, 4Department for Rheumatology and Clinical Immunology, Kerckhoff Clinic, Bad Nauheim, Germany and 5University of Michigan Scleroderma Program, Ann Arbor, MI, USA
Correspondence to: J. R. Seibold, University of Michigan Scleroderma Program, 24 Frank Lloyd Wright Drive, PO Box 481, Lobby M, Suite 2500, Ann Arbor, MI, USA 48106. E-mail: jseibold@umich.edu
| The first 10% of the full text of this article appears below. |
In October of 2007, a group of true experts in diverse areas